This work is licensed under the Creative Commons Attribution 4.0 International License.
Lok C, Frijstein M, van Trommel N. Clinical presentation and diagnosis of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol 2020; 74: 42-52. doi: 10.1016/j.bpobgyn.2020.12.001LokCFrijsteinMvanTrommel NClinical presentation and diagnosis of gestational trophoblastic disease202074425210.1016/j.bpobgyn.2020.12.00133422446Open DOISearch in Google Scholar
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet 2018; 143(Suppl 2): 79-85. doi: 10.1002/ ijgo.12615NganHYSSecklMJBerkowitzRSXiangYGolfierFSekharanPKet alUpdate on the diagnosis and management of gestational trophoblastic disease2018143Suppl 2798510.1002/ijgo.1261530306586Open DOISearch in Google Scholar
Fehlmann A, Benkortbi K, Rosseel G, Meyer-Hamme U, Tille JC, Sloan-Bena F, et al. Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre. Swiss Med Wkly 2021; 151: w20406. doi: 10.4414/smw.2021.20406FehlmannABenkortbiKRosseelGMeyer-HammeUTilleJCSloan-BenaFet alGestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre2021151w2040610.4414/smw.2021.2040633578430Open DOISearch in Google Scholar
Capobianco G, Tinacci E, Saderi L, Dessole F, Petrillo M, Madonia M, et al. High incidence of gestational trophoblastic disease in a third-level university-hospital, Italy: a retrospective cohort study. Front Oncol 2021; 11: 684700. doi: 10.3389/fonc.2021.684700CapobiancoGTinacciESaderiLDessoleFPetrilloMMadoniaMet alHigh incidence of gestational trophoblastic disease in a third-level university-hospital, Italy: a retrospective cohort study20211168470010.3389/fonc.2021.684700813579534026657Open DOISearch in Google Scholar
Eysbouts YK, Bulten J, Ottevanger PB, Thomas CMG, ten Kate-Booij MJ, van Herwaarden AE, et al. Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study. Gynecol Oncol 2016; 140: 70-5. doi: 10.1016/j.ygyno.2015.11.014EysboutsYKBultenJOttevangerPBThomasCMGten Kate-BooijMJvan HerwaardenAEet alTrends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study201614070510.1016/j.ygyno.2015.11.01426586414Open DOISearch in Google Scholar
Hancock BW, Seckl MJ, Berkowitz RS. Gestational trophoblastic disease. London: Hodder Education Publishers; 2022.HancockBWSecklMJBerkowitzRS2022Search in Google Scholar
Soper JT. Gestational trophoblastic disease: current evaluation and management. Obstet Gynecol 2021; 137: 355-70. doi: 10.1097/ AOG.0000000000004240SoperJTGestational trophoblastic disease: current evaluation and management20211373557010.1097/AOG.0000000000004240781344533416290Open DOISearch in Google Scholar
Fisher RA, Maher GJ. Genetics of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol 2021; 74: 29-41. doi: 10.1016/j.bpob-gyn.2021.01.004FisherRAMaherGJGenetics of gestational trophoblastic disease202174294110.1016/j.bpob-gyn.2021.01.004Open DOISearch in Google Scholar
Kaur B. Pathology of gestational trophoblastic disease (GTD). Best Pract Res Clin Obstet Gynaecol 2021; 74: 3-28. doi: 10.1016/j.bpobgyn.2021.02.005KaurBPathology of gestational trophoblastic disease (GTD)20217432810.1016/j.bpobgyn.2021.02.00534219021Open DOISearch in Google Scholar
Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Sook Chon H, et al. Gestational trophoblastic neoplasia, version 2.2019. J Natl Compr Canc Netw 2019; 17: 1374-91. doi: 10.6004/jnccn.2019.0053Abu-RustumNRYasharCMBeanSBradleyKCamposSMSookChon Het alGestational trophoblastic neoplasia, version 2.201920191713749110.6004/jnccn.2019.005331693991Open DOISearch in Google Scholar
Lok C, van Trommel N, Massuger L, Golfier F, Seckl M. Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease. Eur J Cancer 2020; 130: 228-40. doi: 10.1016/j.ejca.2020.02.011LokCvanTrommel NMassugerLGolfierFSecklMPractical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease20201302284010.1016/j.ejca.2020.02.01132247260Open DOISearch in Google Scholar
Cavoretto P, Cioffi R, Mangili G, Petrone M, Bergamini A, Rabaiotti E, et al. A pictorial ultrasound essay of gestational trophoblastic disease. J Ultrasound Med 2020; 39: 597-613. doi: 10.1002/jum.15119CavorettoPCioffiRMangiliGPetroneMBergaminiARabaiottiEet alA pictorial ultrasound essay of gestational trophoblastic disease20203959761310.1002/jum.1511931468566Open DOISearch in Google Scholar
Memtsa M, Johns J, Jurkovic D, Ross JA, Sebire NJ, Jauniaux E. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2020; 253: 206-12. doi: 10.1016/j.ejogrb.2020.07.030MemtsaMJohnsJJurkovicDRossJASebireNJJauniauxEDiagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis20202532061210.1016/j.ejogrb.2020.07.03032877774Open DOISearch in Google Scholar
Jauniaux E, Memtsa M, Johns J, Ross JA, Sebire NJ, Jurkovic D. Ultrasound diagnosis of complete and partial hydatidiform moles in early pregnancy failure: an inter-observer study. Placenta 2020; 97: 65-7. doi: 10.1016/j. placenta.2020.06.013JauniauxEMemtsaMJohnsJRossJASebireNJJurkovicDUltrasound diagnosis of complete and partial hydatidiform moles in early pregnancy failure: an inter-observer study20209765710.1016/j.placenta.2020.06.01332792066Open DOISearch in Google Scholar
Kirk E, Papageorghiou AT, Condous G, Bottomley C, Bourne T. The accuracy of first trimester ultrasound in the diagnosis of hydatidiform mole. Ultrasound Obstet Gynecol 2007; 29: 70-5. doi: 10.1002/uog.3875KirkEPapageorghiouATCondousGBottomleyCBourneTThe accuracy of first trimester ultrasound in the diagnosis of hydatidiform mole20072970510.1002/uog.387517201012Open DOISearch in Google Scholar
Shaaban AM, Rezvani M, Haroun RR, Kennedy AM, Elsayes KM, Olpin JD, et al. Gestational trophoblastic disease: clinical and imaging features. Radiographics 2017; 37: 681-700. doi: 10.1148/rg.2017160140ShaabanAMRezvaniMHarounRRKennedyAMElsayesKMOlpinJDet alGestational trophoblastic disease: clinical and imaging features20173768170010.1148/rg.201716014028287945Open DOISearch in Google Scholar
Jauniaux E, Memtsa M, Johns J, Ross JA, Jurkovic D. New insights in the pathophysiology of complete hydatidiform mole. Placenta 2018; 62: 28-33. doi: 10.1016/j.placenta.2017.12.008JauniauxEMemtsaMJohnsJRossJAJurkovicDNew insights in the pathophysiology of complete hydatidiform mole201862283310.1016/j.placenta.2017.12.00829405964Open DOISearch in Google Scholar
Knez J, Day A, Jurkovic D. Ultrasound imaging in the management of bleeding and pain in early pregnancy. Best Pract Res Clin Obstet Gynaecol 2014; 28: 621-36. doi: 10.1016/j.bpobgyn.2014.04.003KnezJDayAJurkovicDUltrasound imaging in the management of bleeding and pain in early pregnancy2014286213610.1016/j.bpobgyn.2014.04.00324841987Open DOISearch in Google Scholar
Lin LH, Bernardes LS, Hase EA, Fushida K, Francisco RPV. Is Doppler ultrasound useful for evaluating gestational trophoblastic disease? Clinics 2015; 70: 810. doi: 10.6061/clinics/2015(12)08LinLHBernardesLSHaseEAFushidaKFranciscoRPVIs Doppler ultrasound useful for evaluating gestational trophoblastic disease?20157081010.6061/clinics/2015(12)08467632426735221Open DOISearch in Google Scholar
Taylor HS, Pal L, Seli E. Speroff’s clinical gynecologic endocrinology and infertility. Philadelphia: Wolters Kluwer; 2020.TaylorHSPalLSeliEPhiladelphiaWolters Kluwer2020Search in Google Scholar
McMahon LM, Stewart WW, Cuthill L. Human chorionic gonadotrophin assays to monitor GTD. Best Pract Res Clin Obstet Gynaecol 2021; 74: 109-21. doi: 10.1016/j.bpobgyn.2021.05.001McMahonLMStewartWWCuthillLHuman chorionic gonadotrophin assays to monitor GTD2021741092110.1016/j.bpobgyn.2021.05.00134074603Open DOISearch in Google Scholar
Sato A, Usui H, Shozu M. Comparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidi-form moles. Taiwan J Obstet Gynecol 2019; 58: 650-5. doi: 10.1016/j. tjog.2019.07.012SatoAUsuiHShozuMComparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidi-form moles201958650510.1016/j.tjog.2019.07.01231542087Open DOISearch in Google Scholar
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet 2021; 155: 86-93. doi: 10.1002/ijgo.13877NganHYSSecklMJBerkowitzRSXiangYGolfierFSekharanPKet alDiagnosis and management of gestational trophoblastic disease: 2021 update2021155869310.1002/ijgo.13877929823034669197Open DOISearch in Google Scholar
Tidy J, Seckl M, Hancock BW, on behalf of the Royal College of Obstetricians and Gynaecologists. Management of gestational trophoblastic disease. BJOG 2021; 128: e1-27. doi: 10.1111/1471-0528.16266TidyJSecklMHancockBWon behalf of the Royal College of Obstetricians and GynaecologistsManagement of gestational trophoblastic disease2021128e12710.1111/1471-0528.1626632996207Open DOISearch in Google Scholar
Horowitz NS, Eskander RN, Adelman MR, Burke W. Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: a society of gynecologic oncology evidenced-based review and recommendation. Gynecol Oncol 2021; 163: 605-13. doi: 10.1016/j.ygyno.2021.10.003HorowitzNSEskanderRNAdelmanMRBurkeWEpidemiology, diagnosis, and treatment of gestational trophoblastic disease: a society of gynecologic oncology evidenced-based review and recommendation20211636051310.1016/j.ygyno.2021.10.00334686354Open DOISearch in Google Scholar
Ngu SF, Ngan HYS. Surgery including fertility-sparing treatment of GTD. Best Pract Res Clin Obstet Gynaecol 2021; 74: 97-108. doi: 10.1016/j. bpobgyn.2020.10.005NguSFNganHYSSurgery including fertility-sparing treatment of GTD2021749710810.1016/j.bpobgyn.2020.10.005754782633127305Open DOISearch in Google Scholar
Zhao P, Lu Y, Huang W, Tong B, Lu W. Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis. BMC Cancer 2019; 19: 13. doi: 10.1186/s12885-018-5168ZhaoPLuYHuangWTongBLuWTotal hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis2019191310.1186/s12885-018-5168Open DOISearch in Google Scholar
Gockley AA, Lin LH, Davis M, Melamed A, Rizzo A, Sun SY, et al. Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy. Clinics 2021; 76: e2830. doi: 10.6061/clinics/2021/e2830GockleyAALinLHDavisMMelamedARizzoASunSYet alImpact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy202176e283010.6061/clinics/2021/e2830836690134468539Open DOISearch in Google Scholar
Eysbouts Y, Brouwer R, Ottevanger P, Massuger L, Sweep F, Thomas C, et al. Serum human chorionic gonadotropin normogram for the detection of gestational trophoblastic neoplasia. Int J Gynecol Cancer 2017; 27: 1035-41. doi: 10.1097/IGC.0000000000000966EysboutsYBrouwerROttevangerPMassugerLSweepFThomasCet alSerum human chorionic gonadotropin normogram for the detection of gestational trophoblastic neoplasia20172710354110.1097/IGC.000000000000096628498241Open DOISearch in Google Scholar
Snyman LC. Gestational trophoblastic disease: an overview. S Afr J Gynaecol Oncol 2009; 1: 32-7. doi: 10.1080/20742835.2009.11441132SnymanLCGestational trophoblastic disease: an overview2009132710.1080/20742835.2009.11441132Open DOISearch in Google Scholar
Lurain JR. Gestational trophoblastic tumors. Semin Surg Oncol 1990; 6: 347-53. doi: 10.1002/SSU.2980060610LurainJRGestational trophoblastic tumors19906347-5310.1002/SSU.29800606102175931Open DOISearch in Google Scholar
FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee. Int J Gynaecol Obstet 2002; 77: 285-7. doi: 10.1016/S0020-7292(02)00063-2FIGO Oncology CommitteeFIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee200277285710.1016/S0020-7292(02)00063-212065144Open DOISearch in Google Scholar
Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 2010; 203: 531-9. doi: 10.1016/j.ajog.2010.06.073LurainJRGestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole2010203531910.1016/j.ajog.2010.06.07320728069Open DOISearch in Google Scholar
Hancock BW, Tidy J. Placental site trophoblastic tumour and epithelioid trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol 2021; 74: 131-48. doi: 10.1016/j.bpobgyn.2020.10.004HancockBWTidyJPlacental site trophoblastic tumour and epithelioid trophoblastic tumour2021741314810.1016/j.bpobgyn.2020.10.00433139212Open DOISearch in Google Scholar
Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C. Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): 39-50. doi: 10.1093/ annonc/mdt345SecklMJSebireNJFisherRAGolfierFMassugerLSessaCGestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up201324Suppl 6395010.1093/annonc/mdt34523999759Open DOISearch in Google Scholar
Biscaro A, Braga A, Berkowitz RS. Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet 2015; 37: 42-51. doi: 10.1590/SO100-720320140005198BiscaroABragaABerkowitzRSDiagnosis, classification and treatment of gestational trophoblastic neoplasia20153742-5110.1590/SO100-72032014000519825607129Open DOISearch in Google Scholar
Winter MC. Treatment of low-risk gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol 2021; 74: 67-80. doi: 10.1016/j.bpob-gyn.2021.01.006WinterMCTreatment of low-risk gestational trophoblastic neoplasia202174678010.1016/j.bpob-gyn.2021.01.006Open DOISearch in Google Scholar
Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol 2009; 112: 654-62. doi: 10.1016/j.ygy-no.2008.09.005BerkowitzRSGoldsteinDPCurrent management of gestational trophoblastic diseases20091126546210.1016/j.ygy-no.2008.09.005Open DOISearch in Google Scholar
Braga A, Mora P, Melo AC de, Nogueira-Rodrigues A, Amim-Junior J, Rezende-Filho J, et al. Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide. World J Clin Oncol 2019; 10: 28-37. doi: 10.5306/wjco.v10.i2.28BragaAMoraPMeloAC deNogueira-RodriguesAAmim-JuniorJRezende-FilhoJet alChallenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide201910283710.5306/wjco.v10.i2.28639011930815369Open DOISearch in Google Scholar
Clark JJ, Slater S, Seckl MJ. Treatment of gestational trophoblastic disease in the 2020s. Curr Opin Obstet Gynecol 2021; 33: 7-12. doi: 10.1097/ GCO.0000000000000674ClarkJJSlaterSSecklMJTreatment of gestational trophoblastic disease in the 2020s20213371210.1097/GCO.0000000000000674711687233337613Open DOISearch in Google Scholar
Clair KH, Gallegos N, Bristow RE. Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: a case for immune checkpoint salvage therapy in trophoblastic tumors. Gynecol Oncol Rep 2020; 34: 100625. doi: 10.1016/j.gore.2020.100625ClairKHGallegosNBristowRESuccessful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: a case for immune checkpoint salvage therapy in trophoblastic tumors20203410062510.1016/j.gore.2020.100625749098232964090Open DOISearch in Google Scholar
Choi MC, Oh J, Lee C. Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia. Eur J Cancer 2019; 121: 94-7. doi: 10.1016/j.ejca.2019.08.024ChoiMCOhJLeeCEffective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia201912194710.1016/j.ejca.2019.08.02431569067Open DOISearch in Google Scholar
Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, et al. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet 2017; 390: 2343-5. doi: 10.1016/S0140-6736(17)32894-5GhoraniEKaurBFisherRAShortDJoneborgUCarlsonJWet alPembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia20173902343510.1016/S0140-6736(17)32894-529185430Open DOISearch in Google Scholar
Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol 2011; 204: 11-8. doi: 10.1016/j.ajog.2010.06.072LurainJRGestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia201120411810.1016/j.ajog.2010.06.07220739008Open DOISearch in Google Scholar
di Mattei V, Mazzetti M, Perego G, Rottoli S, Mangili G, Bergamini A, et al. Psychological aspects and fertility issues of GTD. Best Pract Res Clin Obstet Gynaecol 2021; 74: 53-66. doi: 10.1016/j.bpobgyn.2020.10.007diMattei VMazzettiMPeregoGRottoliSMangiliGBergaminiAet alPsychological aspects and fertility issues of GTD202174536610.1016/j.bpobgyn.2020.10.00733176992Open DOISearch in Google Scholar